Management

Zydus Cadila files anti-diabetic drug application with DCGI

Healthcare services provider Zydus Cadila has filed an application before the Drugs Controller General of India (DCGI) for its anti-diabetic drug. The company has filed an investigational new drug (IND) application before the DCGI for its ZYD1 drug, used in the treatment of diabetes, Cadila Healthcare, the flagship company of Zydus Cadila group, said in a filing to the Bombay Stock Exchange. The global anti-diabetic market is estimated at Rs 24 billion dollars in 2008.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Record raising of funds in 2010
India Inc lines up Rs 1,50,000 crore equity sales
Popular Articles
payday loan lenders

Gill, Mallya differ widely over Formula One
Barely a day after Force India’s historic podium finish at the Belgian Grand Prix, a war of words broke out between Sports Minister M S Gill and Vijay Mallya on the government’s refusal to acknowledge Formula One as a sport.

Markets volatile, recover from red
The markets have recover after slipping into negative terrain for the second time since morning trades. The NSE Nifty is now at 4,535, up eight points.

© Copyright 2009